Stay updated on Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision tag on the page was updated from v3.6.5 to v3.6.6, indicating a new version of the page was published. This metadata change does not modify the study details or content.SummaryDifference0.1%

- Check27 days agoChange DetectedNo additions or deletions are recorded for this page in the provided changes dataset.SummaryDifference0.1%

- Check34 days agoChange DetectedA new Study Protocol and Statistical Analysis Plan PDF was added to the Study Documents. The data-sharing section was updated to Plan for Individual Participant Data (IPD), reflecting the trial's approach to sharing participant data.SummaryDifference61%

- Check41 days agoChange DetectedThe revision label on the page changed from v3.6.4 to v3.6.5, signaling a new version of the page content or template. This appears to be a routine, minor update that does not modify the study details or user-facing content.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page. This reflects a minor update to the page's metadata and does not affect core content or behavior.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating an updated revision tag on the page.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.